HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Burge, P. S. Search for Related Content PubMed PubMed Citation Articles by Burge, P. S.

Prevention of Exacerbations

How Are We Doing and Can We Do Better?

Birmingham Heartlands Hospital, Birmingham, United Kingdom

Correspondence and requests for reprints should be addressed to Prof. Sherwood Burge, M.D., Birmingham Heartlands Hospital, Birmingham B9 5SS, UK. E-mail: sherwood.burge{at}heartofengland.nhs.uk

ABSTRACT

Prevention of exacerbations of chronic obstructive pulmonary disease (COPD) can involve removing the cause or reducing the patient's vulnerability to the cause. This article addresses the following issues: What is the problem during an exacerbation, what are the causes of an exacerbation, what can prevent exacerbations, and who are we? The difference between a patient with COPD during an exacerbation and after recovery is small. It is unlikely that patients with early COPD experience less exposure to exacerbation causes than those with severe disease; it is just that the consequences are more severe for those with severe disease. Interventions that produce small absolute benefits can therefore have a disproportionately large effect on exacerbation reduction. Recognized causes include season, cold weather, pollution events, bacterial infection, viral infection, and treatment withdrawal. Countries with warmer climates have much larger mortality in cold weather than those with colder climates. Reducing exacerbations in more temperate climates may be altered as much by changes in clothing and bedroom heating as by changes in treatment. Taking more exercise in cold weather may be the underlying reason for the reduction of exacerbations after pulmonary rehabilitation. Influenza vaccination reduces influenza severity and reduces transmission from health care workers to patients. There are a number of pharmacologic interventions shown to reduce (the effect of) exacerbations, including inhaled corticosteroids, long-acting ß-agonists, long-acting anticholinergics, mucolytics, and perhaps antibiotics that reduce Haemophilus carriage. The effect of the bronchodilators is additive to inhaled corticosteroids; how far the other interventions are complementary is unclear. So far, we have had a very medical response to COPD exacerbations. Altering social and behavioral aspects is likely to be complementary.

Key Words: COPD exacerbation • weather • prevention • prophylaxis

This article has been cited by other articles:

				T. Kullmann, I. Barta, B. Antus, M. Valyon, and I. Horvath Environmental temperature and relative humidity influence exhaled breath condensate pH Eur. Respir. J., February 1, 2008; 31(2): 474 - 475. [Full Text] [PDF]

				A. Matsuda, S. Fukuda, K. Matsumoto, and H. Saito Th1/Th2 Cytokines Reciprocally Regulate In Vitro Pulmonary Angiogenesis via CXC Chemokine Synthesis Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 168 - 175. [Abstract] [Full Text] [PDF]